Cours Xtl Biopharma TEL AVIV STOCK EXCHANGE
Actions
IL0010854979
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 5,28 M 1,91 Md 4,72 M |
---|---|---|---|---|---|
Résultat net 2022 | -1 M -362 M -894 k | Résultat net 2023 | -1 M -362 M -894 k | VE / CA 2022 | - |
Trésorerie nette 2022 | 3,72 M 1,35 Md 3,33 M | Trésorerie nette 2023 | 2,01 M 727 M 1,79 M | VE / CA 2023 | - |
PER 2022 |
-4,72
x | PER 2023 |
-2,96
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 93,3% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/12/14 |
Itay Weinstein
DFI | Director of Finance/CFO | 52 | 01/01/99 |
Doron Turgeman
CHM | Chairman | 56 | 30/12/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Shlomo Shalev
CEO | Chief Executive Officer | 62 | 30/12/14 |
Director/Board Member | 57 | 29/01/20 | |
Director/Board Member | 53 | 01/04/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,81% | 46,56 Md | |
+45,38% | 41,67 Md | |
+0,37% | 41,16 Md | |
+31,82% | 32,4 Md | |
+20,82% | 28,18 Md | |
-6,35% | 28,1 Md | |
+49,18% | 14,52 Md | |
+48,11% | 13,74 Md | |
+3,10% | 12,17 Md |